2023/10
We were part of
Defence and Security Equipment International (DSEI) exhibition 2023 in London!
We have been collaborating under our Auto injector Partnership contract with the UK Ministry of Defence (MOD) over the last 2 years, where we have developed a new Nerve Agent Antidote Auto-injector. Following the sucessful manufacture and delivery of the first order to the UK MOD we were subsequently invited to support Strategic Command, Headquarters Defence Medical Services (UK MOD) stand at DSEI exhibition 2023, where we presented our upcoming new device called MELORAI.
MELORAI is a brand new dual-chamber autoinjector developed for the UK MOD. It is the only autoinjector in the world with three active substances – Pralidoxime, Atropine and Midazolam. It should be added to our portfolio in the upcoming years.
2020/6
We are proud to announce that ChemProtect.SK has obtain Cyber essentials certificate of assurance.
2020/3
We are proud to announce that on March 18 2020 ChemProtect.SK s.r.o. became a shareholder of BB Pharma a.s. (bbpharma.cz). Therefore ChemProtect.SK s.r.o. also became a partial owner of all daughter companies of BB Pharma a.s. that are taking part in production of ChemProtect autoinjectors. Related to this is also the newly obtained co-ownership of all certifications, technologies and registrations (GMP,GLP,GDP,…)
2019/2
Pandemic of COVID 19 poses no danger to our production! Due to the strategic nature of our products we do not have (or ever had) any suppliers from China. In addition, we have more than sufficient supplies of raw substances, parts and other necessary materials to keep regular production for at least one year.